Thursday, 28 March 2024


Proteus, Otsuka to collaborate on new medicines

06 July 2012 | News | By BioSpectrum Bureau

Proteus, Otsuka to collaborate on new medicines

Singapore: Proteus Digital Health and Otsuka Pharmaceutical, a subsidiary of Japan-headquartered Otsuka Group, have entered into an exclusive worldwide license and collaboration agreement to develop and commercialize a new category of medicines. These new medicines will be based on Otsuka's pharmaceutical products and Proteus's digital health feedback system incorporating Proteus's novel sensor-based technologies.

Under the agreement, Proteus and Otsuka will exclusively collaborate to develop commercial products in two defined therapeutic areas of high unmet medical need. Otsuka has also been granted a non-exclusive license to utilize Proteus technology in its clinical research and development activities. Financial terms of the agreement were not disclosed.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account